Biopol Chemicals IPO Details
Biopol Chemicals IPO Summary
Biopol Chemicals IPO opens for subscription on 06 Feb 2026 and closes on 10 Feb 2026.The IPO will be listed on NSE with the tentative listing date set for 13 Feb 2026.
Biopol Chemicals IPO price band has been fixed at ₹102 – ₹108 per share. The face value is ₹10 per share with a lot size of 1200.
Biopol Chemicals IPO total issue size comprises 28,94,400 shares (aggregating up to ₹31.26 Cr.). This includes a fresh issue of 28,94,400 shares (aggregating up to ₹31.26 Cr.). Pre-issue shareholding stands at 79,11,000, which will increase to 1,08,05,400 post-issue.
Biopol Chemicals IPO carries a ₹1 (0.93%) GMP, reflecting investor sentiment.
Biopol Chemicals IPO Lot Size :Individual Minimum is 2 lots (2,400 shares) amounting to ₹259,200. Individual Maximum is 2 lots (2,400 shares) amounting to ₹259,200. SHNI Minimum is 3 lots (3,600 shares) amounting to ₹388,800. SHNI Maximum is 7 lots (8,400 shares) amounting to ₹907,200. BHNI Minimum is 8 lots (9,600 shares) amounting to ₹1,036,800.
The Lead Managers for Biopol Chemicals IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Smart Horizon Capital Advisors Pvt Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.
For SME (Small and Medium-sized Enterprise) IPOs, a Market Maker is appointed to ensure liquidity and stability for the stock once it is listed. They do this by continuously quoting bid and ask prices, ensuring there is a market for the shares. The appointed market maker for this IPO is Shreni Shares. You can analyze their track record by checking the Market Maker Performance Summary report.
For detailed information, Refer to the Biopol Chemicals Limited RHP.
Biopol Chemicals IPO Details
Biopol Chemicals IPO Subscription
Biopol Chemicals IPO Application Wise Breakup
Biopol Chemicals IPO Dates
- 06 Feb 2026Opening dateOpen
- 10 Feb 2026Closing dateClose
- 11 Feb 2026Allotment Date Allotment
- 12 Feb 2026Initiation of RefundsRefund
- 12 Feb 2026Credit of SharesCredit
- 13 Feb 2026Listing dateListing
Biopol Chemicals IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual Minimum | 2 | 2400 | ₹259,200 |
| Individual Maximum | 2 | 2400 | ₹259,200 |
| SHNI Minimum | 3 | 3600 | ₹388,800 |
| SHNI Maximum | 7 | 8400 | ₹907,200 |
| BHNI Minimum | 8 | 9600 | ₹1,036,800 |
Biopol Chemicals IPO Reservation
Promoter Holding
Documents
Biopol Chemicals IPO Valuations
Biopol Chemicals Financial Information
| Period Ended | 31 Dec 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 48.88 | 31.48 | 17.56 |
| Total Income | 48.97 | 49.15 | 17.43 |
| Profit After Tax | 6.00 | 4.33 | 2.96 |
| EBITDA | 8.99 | 6.53 | 4.43 |
| NET Worth | 19.54 | 13.53 | 9.20 |
| Reserves and Surplus | 11.63 | 5.62 | 1.29 |
| Total Borrowing | 14.92 | 7.69 | 3.58 |
| Amount in ₹ Crore | |||
About Biopol Chemicals IPO
Biopol Chemicals Limited, incorporated in 2023, is engaged in the manufacturing and distribution of specialty chemicals across silicones, emulsifiers, biochemicals, and polyelectrolytes. The company caters to a diversified range of industrial applications and operates primarily on a business-to-business (B2B) model, serving institutional and industrial customers.
The company’s product portfolio comprises 66 products, including silicone-based products, emulsifiers, biochemical products, and polyelectrolytes. These products find application across multiple end-use industries such as textiles, home care, agriculture, and industrial chemicals, addressing both performance and process-specific requirements of customers.
Biopol Chemicals Limited operates through four establishments located in Gujarat and West Bengal, which include its manufacturing unit, corporate office, and warehouse in West Bengal, and its registered office in Gujarat. The manufacturing facility has an installed capacity of 18,25,000 litres per annum, enabling efficient and scalable production of its specialty chemical offerings.
As of December 31, 2025, the company employed 24 personnel, supporting its manufacturing, sales, administrative, and operational functions.
Strength Of Biopol Chemicals IPO
- Our Order Book.
- Our Manufacturing Unit.
- Quality Certification and Quality Assurance.
- Strategic presence in Gujarat and West Bengal.
- Experienced Promoter and Management Team.
- Export operations in Bangladesh.
Risk Of Biopol Chemicals IPO
- The company's speciality chemicals are used in the textile segment and its business is significantly dependent on the textile industry. Any adverse developments in that industry may materially and adversely affect the company's business, financial condition, results of operations and cash flows.
- A significant portion of its revenue is derived from customers located in West Bengal, Gujarat and Bangladesh. Any adverse developments in these regions may materially and adversely affect the company's business, financial condition, results of operations and cash flows.
- The Company is dependent on a limited number of suppliers for the procurement of critical raw materials. The loss of any of these suppliers or disruption in supply may materially and adversely affect its business operations, financial condition, results of operations and cash flows.
- The company's revenue is derived through a combination of direct sales and distributor-driven sales, and any disruption or inefficiency in either channel may materially and adversely affect its business, financial condition, results of operations and cash flows. Additionally, we do not have long-term agreements with certain distributors, which exposes it to the risk of losing them or facing unfavourable commercial terms.
- The company depends on a limited number of key customers for a substantial portion of its revenue and any loss of, or reduction in business from such customers could materially and adversely affect the company's business, results of operations, cash flows and financial condition. The company does not have any agreements with these customers for repeat business, and the comoany cannot assure that the company will generate the same quantum of business, or any business at all, from them. Any decline in the quality of its products or services, growing competition, changes in customer preferences, or a shift by customers to other suppliers could adversely affect our ability to retain these key customers. Loss of business from one or more of our major customers could materially reduce the company's revenue and profitability.
- The company operates business premises from leased properties and do not hold ownership rights in such properties. All lease and rental agreements entered into for these properties are not registered. Any termination, non-renewal, or unfavourable revision of lease terms or any limitations arising from the unregistered nature of these agreements, may materially and adversely affect its business, operations, financial condition, results of operations, and cash flows.
- The company's manufacturing unit situated in Kolkata, West Bengal is critical for its business and any disturbance, slowdown or shutdown of the company's Kolkata manufacturing unit, may have an adverse impact on its business, results of operations and financial conditions.
- The company's revenue is derived from a combination of manufacturing, trading, and technical consultancy activities, and any disruption, decline, or inefficiency in any of these segments may materially and adversely affect its business, financial condition, results of operations, and cash flows.
- Improper handling of its products or spoilage and damage to the company's products, could damage its reputation and may have an adverse effect on the company's business, results of operations and financial condition.
- There are certain inadvertent errors noticed in some of its corporate records relating to forms filed with the Registrar of Companies and other provisions of Companies Act, 2013. Any penalty or action taken by any regulatory authorities in future, for non-compliance with provisions of corporate and other law could impact the reputation and financial position of the Company to that extent.
Objectives Biopol Chemicals IPO
1. Acquisition of industrial land
2. Repayment or prepayment, in full or in part, of borrowings availed by the Company from banks, financial institutions and non-banking financial companies
3. General Corporate Purposes
Company Contact Details
Biopol Chemicals Ltd.
D-211, 2nd Floor, Block-D,
Sumel Business Park-6 Near Dudheshwar Circle
Dudheshwar Tavdipura
Ahmedabad, Gujarat, 380004
Phone: +91- 9147076778
Email: investors@biopolchemicals.com
Website: https://biopolchemicals.com/
Registrar Contact Details
Biopol Chemicals FAQs
The Biopol Chemicals IPO is a SME public issue comprising 2894400 equity shares with a face value of ₹10 each, aggregating to a total issue size of ₹31.26 Cr.. The issue price has been fixed at ₹108 per equity share, and the minimum application size is 1200 shares.
The IPO opens for subscription on 06 Feb 2026, and closes on 10 Feb 2026.
Bigshare Services Pvt Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the NSE
As of now, the current GMP stands at ₹1 (0.93%).
Quick Links
Comments
